Melendez-Zajgla J - Search Results

1

Advances in the knowledge of breast cancer stem cells. A review.

Schwarz-Cruz Y Celis A, Espinosa M, Maldonado V, Melendez-Zajgla J. Schwarz-Cruz Y Celis A, et al. Histol Histopathol. 2016 Jun;31(6):601-12. doi: 10.14670/HH-11-718. Epub 2015 Dec 30. Histol Histopathol. 2016. PMID: 26715540 Review.

2

Germline mutations in pediatric cancer cohort with mixed-ancestry Mexicans.

Alonso-Luna O, Mercado-Celis GE, Melendez-Zajgla J, Barquera R, Zapata-Tarres M, Juárez-Villegas LE, Mendoza-Caamal EC, Rey-Helo E, Borges-Yañez SA. Alonso-Luna O, et al. Among authors: melendez zajgla j. Mol Genet Genomic Med. 2024 Jan;12(1):e2332. doi: 10.1002/mgg3.2332. Epub 2023 Dec 13. Mol Genet Genomic Med. 2024. PMID: 38093606 Free PMC article.

3

Subcellular redistribution of HSP72 protein during cisplatin-induced apoptosis in HeLa cells.

Meléndez-Zajgla J, García C, Maldonado V. Meléndez-Zajgla J, et al. Biochem Mol Biol Int. 1996 Oct;40(2):253-61. doi: 10.1080/15216549600201742. Biochem Mol Biol Int. 1996. PMID: 8896747

4

Paclitaxel-induced apoptosis in HeLa cells is serum dependent.

Maldonado V, De Anda J, Meléndez-Zajgla J. Maldonado V, et al. J Biochem Toxicol. 1996;11(4):183-8. doi: 10.1002/(SICI)1522-7146(1996)11:4<183::AID-JBT3>3.0.CO;2-G. J Biochem Toxicol. 1996. PMID: 9062848

5

Modulation of NF-kappa B, and Bcl-2 in apoptosis induced by cisplatin in HeLa cells.

Maldonado V, Meléndez-Zajgla J, Ortega A. Maldonado V, et al. Mutat Res. 1997 Nov 19;381(1):67-75. doi: 10.1016/s0027-5107(97)00150-4. Mutat Res. 1997. PMID: 9403032

6

Cisplatin-induced apoptosis of HeLa cells. Effect of RNA and protein synthesis inhibitors, Ca2+ chelators and zinc.

Velázquez M, Maldonado V, Melendez-Zajgla J. Velázquez M, et al. J Exp Clin Cancer Res. 1998 Sep;17(3):277-84. J Exp Clin Cancer Res. 1998. PMID: 9894762

7

Mitochondrial changes during the apoptotic process of HeLa cells exposed to cisplatin.

Melendez-Zajgla J, Cruz E, Maldonado V, Espinoza AM. Melendez-Zajgla J, et al. Biochem Mol Biol Int. 1999 May;47(5):765-71. doi: 10.1080/15216549900201853. Biochem Mol Biol Int. 1999. PMID: 10365247

8

Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine.

Bandala E, Espinosa M, Maldonado V, Meléndez-Zajgla J. Bandala E, et al. Biochem Pharmacol. 2001 Jul 1;62(1):13-9. doi: 10.1016/s0006-2952(01)00632-3. Biochem Pharmacol. 2001. PMID: 11377392

9

Gemcitabine activity in cervical cancer cell lines.

Hernández P, Olivera P, Dueñas-Gonzalez A, Pérez-Pastenes MA, Zárate A, Maldonado V, Meléndez-Zajgla J. Hernández P, et al. Cancer Chemother Pharmacol. 2001 Dec;48(6):488-92. doi: 10.1007/s002800100370. Cancer Chemother Pharmacol. 2001. PMID: 11800030

10

Estrogen receptor expression in giant cell tumors of the bone.

Olivera P, Perez E, Ortega A, Terual R, Gomes C, Moreno LF, Dueñas A, De La Garza J, Melendez-Zajgla J, Maldonado V. Olivera P, et al. Hum Pathol. 2002 Feb;33(2):165-9. doi: 10.1053/hupa.2002.31476. Hum Pathol. 2002. PMID: 11957140

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters